Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Research ArticleRadionuclide Therapy

First-Strike Rapid Predictive Dosimetry and Dose Response for 177Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer

Yung Hsiang Kao, Nadia Falzone, Michael Pearson and Dinesh Sivaratnam
Journal of Nuclear Medicine Technology September 2024, 52 (3) 212-218; DOI: https://doi.org/10.2967/jnmt.123.267067
Yung Hsiang Kao
1Department of Nuclear Medicine, Royal Melbourne Hospital, Parkville, Victoria, Australia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nadia Falzone
2GenesisCare Theranostics, North Shore Health Hub, Sydney, New South Wales, Australia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Pearson
3Medical Imaging Department, Cabrini Hospital, Malvern, Victoria, Australia; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dinesh Sivaratnam
1Department of Nuclear Medicine, Royal Melbourne Hospital, Parkville, Victoria, Australia;
3Medical Imaging Department, Cabrini Hospital, Malvern, Victoria, Australia; and
4GenesisCare Theranostics, Cabrini Hospital, Malvern, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 52 no. 3 212-218
DOI 
https://doi.org/10.2967/jnmt.123.267067
PubMed 
38901967

Published By 
Society of Nuclear Medicine
Print ISSN 
0091-4916
Online ISSN 
1535-5675
History 
  • Received for publication November 16, 2023
  • Accepted for publication April 23, 2024
  • Published online September 5, 2024.

Article Versions

  • previous version (June 20, 2024 - 06:02).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2024 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Yung Hsiang Kao1,
  2. Nadia Falzone2,
  3. Michael Pearson3 and
  4. Dinesh Sivaratnam1,3,4
  1. 1Department of Nuclear Medicine, Royal Melbourne Hospital, Parkville, Victoria, Australia;
  2. 2GenesisCare Theranostics, North Shore Health Hub, Sydney, New South Wales, Australia;
  3. 3Medical Imaging Department, Cabrini Hospital, Malvern, Victoria, Australia; and
  4. 4GenesisCare Theranostics, Cabrini Hospital, Malvern, Victoria, Australia
  1. For correspondence or reprints, contact Yung Hsiang Kao (yung.kao{at}mh.org.au).
View Full Text

Statistics from Altmetric.com

Cited By...

  • 1 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Direct Correlation of Tumor Absorbed Dose with Overall Survival in Metastatic Castration-Resistant Prostate Cancer Treated with177Lu Prostate-Specific Membrane Antigen
    Yung Hsiang Kao
    Journal of Nuclear Medicine Technology 2025

Article usage

Article usage: June 2024 to April 2025

AbstractFullPdf
Jun 20249961411
Jul 20247822711
Aug 202431775
Sep 20247604226
Oct 20245201712
Nov 20244283019
Dec 20242001510
Jan 2025179187
Feb 2025159218
Mar 202511354
Apr 202513665
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 52 (3)
Journal of Nuclear Medicine Technology
Vol. 52, Issue 3
September 1, 2024
  • Table of Contents
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
First-Strike Rapid Predictive Dosimetry and Dose Response for 177Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
First-Strike Rapid Predictive Dosimetry and Dose Response for 177Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
Yung Hsiang Kao, Nadia Falzone, Michael Pearson, Dinesh Sivaratnam
Journal of Nuclear Medicine Technology Sep 2024, 52 (3) 212-218; DOI: 10.2967/jnmt.123.267067

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
First-Strike Rapid Predictive Dosimetry and Dose Response for 177Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
Yung Hsiang Kao, Nadia Falzone, Michael Pearson, Dinesh Sivaratnam
Journal of Nuclear Medicine Technology Sep 2024, 52 (3) 212-218; DOI: 10.2967/jnmt.123.267067
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • ACKNOWLEDGMENTS
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Direct Correlation of Tumor Absorbed Dose with Overall Survival in Metastatic Castration-Resistant Prostate Cancer Treated with 177Lu Prostate-Specific Membrane Antigen
  • Google Scholar

More in this TOC Section

  • Direct Correlation of Tumor Absorbed Dose with Overall Survival in Metastatic Castration-Resistant Prostate Cancer Treated with 177Lu Prostate-Specific Membrane Antigen
  • Survey of Clinical Protocols for the Use of 177Lu-PSMA-617 in the United States
Show more Radionuclide Therapy

Similar Articles

Keywords

  • 177Lu-prostate-specific membrane antigen
  • dosimetry
  • marrow
  • metastatic castration-resistant prostate cancer
  • theranostics
SNMMI

© 2025 SNMMI

Powered by HighWire